Medpace
MEDP
386 hedge funds and large institutions have $6.22B invested in Medpace in 2021 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 123 increasing their positions, 151 reducing their positions, and 20 closing their positions.
255% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 20
15% more capital invested
Capital invested by funds: $5.42B → $6.22B (+$807M)
15% more funds holding
Funds holding: 337 → 386 (+49)
12% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $11.4M
0.15% less ownership
Funds ownership: 79.91% → 79.75% (-0.15%)
19% less repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 151
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$44.1M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$29.7M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$29.3M |
| 4 |
Goldman Sachs
New York
|
+$14.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$51.8M |
| 2 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
-$16.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$16.7M |
| 4 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$15.9M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$12.9M |
MEDP Hedge Fund Activity: Q4 2021 in Review
386 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2021, worth a combined $6.22B — up 15% from $5.42B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new MEDP positions and 20 closed out — a net gain of 51 holders — while 123 added to existing stakes and 151 trimmed.
The largest buyer was Franklin Resources, adding an estimated $44.1M. The largest seller was Aberdeen Group, cutting an estimated $51.8M.
- 386 institutional investors held Medpace (MEDP) as of Q4 2021, up from 337 in Q3 2021.
- Funds reported $6.22B of Medpace stock for Q4 2021, up 15% quarter-over-quarter.
- 71 funds opened new Medpace positions in Q4 2021 and 20 closed out, a net change of +51 holders.
- The largest Medpace buyer in Q4 2021 was Franklin Resources, an estimated $44.1M added.
- The largest Medpace seller in Q4 2021 was Aberdeen Group, an estimated $51.8M sold.
Based on aggregated 13F filings for Q4 2021.